Picture this: you’re on a rollercoaster, the first big drop just hit, and your stomach flips. That’s exactly how Indian traders felt today as Nifty and Bank Nifty both lost ground after five straight sessions of weakness.
- Nifty 50 closed at 24,891, down 166 points (-0.66%)
- Bank Nifty ended at 54,389, slipping 586 points (-1.07%)
Add to that a surprise twist — Donald Trump’s 100% tariff threat on pharma imports — and you get a market packed with uncertainty.
But here’s the good news: volatility also brings opportunity. Market veterans like Anil Singhvi, Managing Editor at Zee Business, have laid out clear support and resistance zones to help traders navigate this turbulence.
Let’s break down what happened, why it matters, and how to plan your trades in the coming sessions.
Nifty 50: Support, Resistance, and Sentiment
The Nifty index has been under pressure, breaking below the psychological 25,000 level. Technical experts note that:
- Support zones: 24,800–24,700 (immediate), with a stronger buy zone at 24,525–24,625
- Resistance zones: 25,000–25,100 (near-term), and a stronger sell zone at 25,085–25,200
📊 On the technical side:
- RSI slipped below 50, showing weakening momentum
- Heavy call writing around 25,000 is capping the upside
- Multiple analysts see “sell on rise” as the best strategy unless Nifty reclaims 25,050 decisively
🧠 What You Should Remember:
Nifty is like a car stuck in second gear — until it crosses 25,050 and holds, upward momentum will be limited. For now, rallies may attract sellers.
Bank Nifty: The Real Pressure Point
If Nifty was shaky, Bank Nifty was outright weak. The index closed at 54,389, making a five-day losing streak.
- Support levels (Anil Singhvi): 54,450–54,575 (near-term), 54,200–54,400 (stronger support)
- Resistance levels: 55,150–55,275 (higher zone), 55,350–55,500 (strong sell zone)
📊 Technical indicators:
- RSI dipped under 50, confirming bearish bias
- Call writing near 55,200 and 55,500 is creating strong resistance
- Momentum suggests 54,500 could be tested again if weakness continues
🧠 What You Should Remember:
Think of Bank Nifty as the captain of the cricket team — when it struggles, the whole squad feels the heat. Unless it reclaims 55,200+, bearish sentiment will dominate.
Anil Singhvi’s Trading Strategy
Here’s how Singhvi framed his market plan for Friday, September 26, 2025:
For Nifty 50
- Long positions: Keep stop loss at 24,800
- Short positions: Keep stop loss at 25,100
- New trades:
- Sell below 25,000 with targets of 24,800, 24,750, 24,700
- Aggressive traders can buy near 24,575–24,700 with a stop loss at 24,500
For Bank Nifty
- Long positions: Stop loss at 54,700
- Short positions: Stop loss at 55,350
- New trades:
- Sell near 55,000 with targets of 54,750, 54,700, 54,575, 54,525
- Aggressive traders can buy near 54,400–54,575 with a stop loss at 54,200
🧠 What You Should Remember:
Singhvi’s approach is like cricket field placements — he marks the zones where batsmen (traders) can score and where bowlers (market forces) will trap them. Stick to the zones, and you can avoid unnecessary losses.
Trump’s Pharma Tariffs: A Storm on the Horizon
Markets weren’t just battling technicals today — geopolitics added spice. Former US President Donald Trump announced a 100% tariff on pharma imports, targeting countries like India.
Why This Matters to India
- India supplies 47% of the US’s generic drugs
- US pharma imports from India are high in volume but lower in value (generics are cheaper)
- Generics save the US $400 billion annually
So, while Trump’s policy sounds harsh, the actual damage to Indian pharma earnings may be limited.
But here’s the catch: sentiment. Just like IT stocks stayed weak after the H-1B visa scare, pharma stocks too may remain under pressure, even if fundamentals aren’t badly hit.
Stocks to Watch
- Less affected: Cipla, Dr. Reddy’s, Lupin (have US plants)
- Generics heavyweights: Aurobindo, Cipla, Dr. Reddy’s dominate US generics
- Risk: All pharma stocks may dip initially on sentiment before stabilizing
🧠 What You Should Remember:
This is like rain in cricket — the match may pause, but it doesn’t change the long-term result. Pharma fundamentals stay intact; negative headlines may just offer buying opportunities.
Trading Strategies in This Volatile Market
With both indices showing weakness, experts recommend defined-risk strategies over naked directional bets.
Bear Call Spreads (Options)
- For Nifty: Sell 24,700 CE, buy 25,000 CE → max profit ₹15,458
- For Bank Nifty: Sell 54,700 CE, buy 55,100 CE → max profit ₹9,058
These spreads let traders profit from downside moves while capping losses.
Risk Management Rules
- Always use strict stop losses
- Avoid overleveraging during high volatility
- Track global cues (Dow futures, oil prices, Trump policies)
🧠 What You Should Remember:
Trading without a stop loss is like driving without brakes. In volatile sessions, survival is the first win.
Bigger Picture: Is the Uptrend Broken?
Despite short-term pain, analysts stress that the long-term structure remains intact.
- Nifty has rallied 4.28% in the past month before cooling off
- Bank Nifty also surged earlier but is now consolidating
- Fibonacci retracements show supports around 24,800 (Nifty) and 54,700 (Bank Nifty)
As long as these supports hold, the broader bull market is alive.
🧠 What You Should Remember:
Think of this correction as a “timeout” in a T20 match. The innings is still on — the team (bulls) just needs to regroup before attacking again.
